fgfr-specific tkis versus multikinase inhibitors
Published 5 years ago • 136 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
7:25
fgfr inhibitor clinical trials
-
4:25
fgfr inhibitor moa and adverse events
-
5:16
the future of fgfr inhibitor treatment
-
6:00
fgfr inhibitor toxicity profile
-
4:12
fgfr2 inhibitors in advanced cholangiocarcinoma
-
4:15
multikinase inhibitor overall survival advantage
-
3:12
the development of fgfr inhibitors
-
7:31
fgfr inhibition in advanced cca
-
1:47
fgfr versus chemotherapy: dcr/dor efficacy
-
44:45
targeting fgfr alterations in cancer with a selective fgfr inhibitor - dr. randi isaacs
-
4:03
fgfr inhibitors for cca & bladder cancer
-
2:29
additional insights: experience with fgfr inhibitors in bladder cancer
-
3:08
is fgfr inhibition an effective target in gastrointestinal tumors?
-
1:00:01
webinar: targeting the fgfr pathway: infigratinib in cholangiocarcinoma
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
0:46
what are fgfr inhibitors?
-
9:55
fgfr inhibitors in development for cca
-
0:31
impact of #fgfr inhibitors in #bladdercancer #cancer #uc #news #cancerresearch